RecruitingNCT04300257
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
Sponsor
Kantonsspital Winterthur KSW
Enrollment
600 participants
Start Date
Oct 19, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
The primary significance of this project is to perform a detailed analysis to assess the diagnostics, treatment and follow-up care, to develop a prediction model for future patient selection regarding various diagnostic and treatment procedures.
Eligibility
Inclusion Criteria2
- Malignant and intermediate and selected benign bone or soft tissue tumors, acc. to the WHO coding list of the SSN
- Female and male subjects of all ages
Exclusion Criteria1
- Documented objection of subsequent use of personal health data
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04300257
Related Trials
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
NCT023907521 location
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
NCT011093945 locations
Phase II Trial of Lung Chemoemobolization
NCT056721082 locations
IDOV-Immune for Advanced Solid Tumors
NCT069106576 locations
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
NCT017727711 location